Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

New Strategies to Detect Cancers in Carriers of Mutations in RB1: Blood Tests Based on Tumor-educated Platelets, or Extracellular Vesicles.

NCT04164134 is registered in ClinicalTrials.gov with Amsterdam UMC, location VUmc as lead sponsor.

NCT NCT04164134
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04164134 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
New Strategies to Detect Cancers in Carriers of Mutations in RB1: Blood Tests Based on Tumor-educated Platelets, or Extracellular Vesicles.
Lead sponsor
Amsterdam UMC, location VUmc
Phase
Observational
Overall status
Completed
Start date
December 13, 2018
Completion date
March 31, 2023
Enrollment
378 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

retinoblastoma, secondary primary malignancies after retinoblastoma